Pharmacy Technician Required Classes -Pharmacy Law: Controlled Drug Diversion

---

ONLINEPharmacy TechniciansPharmacy Law

Pop-up Blockers

Tuesday, February 7, 2023, 6:00 AM - Wednesday, February 7, 2024, 6:00 PM CST


ACPE Contact Hour(s) (1.00 hours)

This activity will provide a legal overview of Drug Diversion, specifically focusing on Chain of Custody.  After this activity, the Pharmacy Technician will be able to describe the Chain of Custody, identify opportunities for diversion and endorse changes to the Technician's role in reducing controlled drug diversion in a hospital setting.

Disclosures:

Faculty: Bradley N. Nix, PharmD
* Has no relevant financial relationships with ACCME-defined commercial interests
* Will not be discussing the off-label or investigational use of products
* All Ascension planners and reviewers have no relevant financial relationships with ACCME-defined commercial interests.

Course Chair reviewed and found no Conflict of Interest

1. Describe the chain of custody in terms of managing controlled drug diversion
2. Identify potential opportunities for controlled drug diversion within the chain of custody
3. Endorse the pharmacy technicians role in reducing controlled drug diversion

This activity was planned by and for the healthcare team, and learners will receive 1.00 IPCE credits for learning and change.

Ascension adheres to ACCME Criteria, Standards and Policies regarding industry support of CE/CME. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Ascension adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Commercial Interest: No commercial interest was received for this CE/CME activity.